Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.

Dabigatran and rivaroxaban are novel oral anticoagulants that specifically inhibit thrombin and factor Xa, respectively. The aim of this study is to elucidate antithrombotic properties of these anticoagulant agents under arterial and venous shear conditions. Whole blood samples treated with dabigatr...

Full description

Bibliographic Details
Main Authors: Kazuya Hosokawa, Tomoko Ohnishi, Hisayo Sameshima, Naoki Miura, Takehiko Koide, Ikuro Maruyama, Kenichi A Tanaka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3908954?pdf=render